Synapse

← JHEP Reports

Papers in JHEP Reports

Page 4 · newest first

  1. Efficacy and Safety of Immune Checkpoint Inhibitors-based Therapy in Patients with High Microsatellite Instability/Mismatch Repair–Deficient Advanced Cholangiocarcinoma: A Propensity Score–Matched StudyJHEP Reports · 2026
  2. Multicenter study of bleeding and thromboembolic events with durvalumab tremelimumab vs. atezolizumab and bevacizumab in advanced HCCJHEP Reports · 2026
  3. Large cohort studies assessing sex associations between anthropometric indices and liver cancer deathJHEP Reports · 2026
  4. Deep learning-based generation of synthetic multiphasic MRI in hepatocellular carcinoma and cirrhosisJHEP Reports · 2026
  5. Spatial-quantitative profiling of intrahepatic HBsAg heterogeneity and clustered distribution in chronic HBV infectionJHEP Reports · 2026
  6. Hemodiafiltration improves performance of 24 hour ex situ normothermic liver machine perfusionJHEP Reports · 2026
  7. Prognostic value of Factor VIII, D-Dimer and High Molecular Risk variants assessing re-thrombosis risk in non-cirrhotic portal vein thrombosis☆JHEP Reports · 2026
  8. CD36-PPARγ-SPP1 axis mediates hepatocyte-macrophage coordination to drive MASLD-related liver fibrosisJHEP Reports · 2026
  9. The qEEG-TIPS score: development of a predictive model for recurrent overt hepatic encephalopathy after elective TIPSJHEP Reports · 2026
  10. AI-assisted fibrosis scoring in MASH: Exploring pathologist decision-making with an SHG-based AI digital pathology toolJHEP Reports · 2026
  11. The endonuclease MCPIP1 protects against liver cancer development in a sex-dependent manner by modulating β-catenin and CREB1JHEP Reports · 2026
  12. Management of obesity in advanced chronic liver diseaseJHEP Reports · 2026
  13. Comparative evaluation of regression and machine-learning models for hepatocellular carcinoma risk stratification across diverse aetiologiesJHEP Reports · 2026
  14. EASL position paper on palliative care in advanced chronic liver diseaseJHEP Reports · 2026
  15. Beyond cancer: CAR-T cells redefining liver disease therapyJHEP Reports · 2026
  16. Performance of reMELD-Na as a predictor of short-term mortality in patients with cirrhosis and ascitesJHEP Reports · 2026
  17. Nucleotide excision repair and poly(ADP-ribose) polymerase 1 cooperate in HBV cccDNA synthesis: A potential viral therapeutic targetJHEP Reports · 2026
  18. Spatial profiling defines three immunophenotypes and a perineural invasion-associated immune-evasion niche in gallbladder cancerJHEP Reports · 2026
  19. Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management☆JHEP Reports · 2026
  20. Coagulation protease-activated receptor-2 (PAR2) promotes dyslipidemia, obesity and MASLD through repression of the hepatic pioneer factor HNF4αJHEP Reports · 2026
  21. Pre-liver transplant assessment of patients with acute-on-chronic liver failure: An international surveyJHEP Reports · 2026
  22. Pattern of progression and post-progression survival following transarterial embolisation: An analysis of the TACE-2 and TACTICS trialsJHEP Reports · 2026
  23. Disease-driven loss of inactive HSD17B13 isoforms enhances enzymatic output in MASH and counters protective rs72613567:TA variantJHEP Reports · 2026
  24. Very Low Energy Ketogenic Diet vs Mediterranean Diet for MASLD: Superior Steatosis Reduction in a Randomised Pilot StudyJHEP Reports · 2026
  25. ADCY7 dictates N-cadherin stability to inhibit HCC metastasisJHEP Reports · 2026
  26. Comparative performance of ReMELD-Na, MELD 3.0 and established scores after TIPS for refractory ascites: A multicenter studyJHEP Reports · 2026
  27. Impact of sex on chemotherapy toxicity and efficacy in biliary tract cancer: Analysis of ABC, BILCAP trials and population dataJHEP Reports · 2026
  28. A thioacrylamide-based compound directly counteracts hepatic fibrosis with profound anti-obesity actionJHEP Reports · 2026
  29. Multiomics and multi-region spatial transcriptome analysis reveal cellular networks and pathways associated with HCC recurrenceJHEP Reports · 2026
  30. Molecular endoscopy with next-generation sequencing improves diagnosis of cholangiocarcinoma in patients with extrahepatic biliary stricturesJHEP Reports · 2026
  31. H4K5 lactylation - ENO2 loop drives glycolysis and HCC progressionJHEP Reports · 2026
  32. Mass spectrometry-based de novo sequencing reveals non-canonical neoantigens with antitumor efficacy in hepatocellular carcinomaJHEP Reports · 2026
  33. Genetic and lifestyle modifiers of haemochromatosis-related clinical outcomes in HFE C282Y homozygotesJHEP Reports · 2026
  34. Unaddressed concerns of potential follow-up bias in the international PSC registryJHEP Reports · 2026
  35. Liver sinusoidal endothelial TGF-β signaling accelerates partial endothelial–mesenchymal transition and MASH through NotchJHEP Reports · 2026
  36. IL4I1+ macrophages drive hepatocellular carcinoma progression by responding to biomechanical cuesJHEP Reports · 2026
  37. Glycodeoxycholic acid inhibits hepatocellular carcinoma by driving M1 polarization of macrophages via the S1PR2–NF-κB–NLRP3 pathwayJHEP Reports · 2026
  38. Single-cell transcriptomics reveals the impact of sex and age in the healthy human liverJHEP Reports · 2026
  39. Single-cell fixed RNA profiling uncovers SEMA4D and LMCD1 as therapeutic targets in a liver fibrosis modelJHEP Reports · 2026
  40. Underuse of statins in MASLD despite population-based associations with lower liver stiffnessJHEP Reports · 2026
  41. MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trialJHEP Reports · 2026
  42. New histopathological terminology for well-differentiated hepatocellular lesions in unusual clinico-pathological scenarios: HCA-like and FNH-likeJHEP Reports · 2026
  43. Perineural invasion is a prognostic factor in cholangiocarcinoma, regardless of anatomical location: A systematic review and meta-analysisJHEP Reports · 2026
  44. Real-world quality of life and healthcare resource utilization in patients with metabolic dysfunction-associated steatohepatitisJHEP Reports · 2026
  45. Safety and effectiveness of phenobarbital vs. benzodiazepines for severe alcohol withdrawal in alcohol-associated liver disease in the ICUJHEP Reports · 2026
  46. Comparison of patients with HCC with and without MASLD after surgical resectionJHEP Reports · 2026
  47. Platelets accelerate endoplasmic reticulum stress and promote hepatic steatosisJHEP Reports · 2026
  48. Long-term outcomes of baseline grey-zone patients with HBeAg-negative chronic hepatitis B virus infectionJHEP Reports · 2026
  49. Evaluation and management of primary sclerosing cholangitis patients awaiting liver transplantationJHEP Reports · 2026
  50. Temporal trends and racial/ethnic disparities in hepatocellular carcinoma incidence in the US between 2000-2022JHEP Reports · 2026